Poly (ADP-ribose) glycohydrolase (PARG) is a catabolic enzyme that degrades PARylated chains, releasing ADP-ribose and oligo (ADP-ribose) chains . PARG activity is linked to cellular responses in inflammation, ischemia, stroke, and cancer . PARG, along with poly(ADP-ribose) polymerases (PARPs), regulates PAR homeostasis in response to cellular stress, such as DNA damage .
PARG-1 interacts with both axial and central elements of the synaptonemal complex, REC-8/Rec8, and the MRN/X complex in Caenorhabditis elegans . PARG-1 influences the recombination landscape and reinforces the tightly regulated control of crossover numbers without requiring its catalytic activity . PARG-1 is recruited to the synaptonemal complex (SC) in an HTP-3-dependent manner, and its localization changes in response to CO-mediated chromosome remodeling . Immunoprecipitation assays showed a robust interaction between HTP-3::GFP and PARG-1 . PARG-1 also co-immunoprecipitates with HTP-1 and REC-8 .
PARG is overexpressed in breast cancer and is associated with tumor growth and survival . Decreasing PARG activity can enhance the effect of current cancer therapies, such as chemotherapy and radiation, making PARG inhibition with selective inhibitors a promising approach in cancer and immunotherapy .
STRING: 6239.F20C5.1a
UniGene: Cel.6484
PARG-1/pme-3 in C. elegans has revealed an unexpected role beyond its canonical function in poly(ADP-ribose) catabolism. Studies have demonstrated that PARG-1 is involved in coordinating meiotic DNA double-strand break (DSB) formation and homologous recombination-mediated repair . This function appears to be independent of its catalytic activity in poly(ADP-ribose) hydrolysis.
Specifically, PARG-1 promotes:
The induction of meiotic DNA breaks
Homologous recombination-mediated repair of these breaks
Regulation of crossover numbers and distribution (shaping the recombination landscape)
The critical nature of PARG-1 is evidenced by repair defects observed in mutants. When PARG-1 function is compromised alongside mutations in other DNA repair genes, such as mre-11, repair efficiency is significantly reduced, suggesting that PARG-1 influences DNA repair pathway choice .
PARG-1/pme-3 interacts with multiple components of the meiotic machinery to facilitate proper DSB formation and repair:
Synaptonemal complex components: PARG-1 associates with both axial and central elements of the synaptonemal complex
Cohesins: Interacts with REC-8/Rec8, a meiosis-specific cohesin component
MRN/X complex: Co-immunoprecipitation studies revealed interaction with MRE-11, a component of the MRN/X complex involved in DSB processing
HTP-3: Interacts with this axial element component which is known to promote meiotic DSB formation
These interactions position PARG-1 within critical meiotic protein assemblies. Co-immunoprecipitation experiments with MRE-11::GFP have confirmed the physical association between PARG-1 and MRE-11, suggesting a molecular mechanism by which PARG-1 might influence DSB formation . The interaction with HTP-3, which itself interacts with MRE-11, provides additional support for PARG-1's involvement in a pro-DSB formation pathway that operates parallel to other known pathways involving factors like HIM-17, HIM-5, and DSB-2 .
PARG-1/pme-3, like other PARGs, catalyzes the hydrolysis of glycosidic bonds of ADP-ribose polymers. Its biochemical activity includes:
Endoglycosidase activity: Cleaves internal glycosidic bonds within PAR chains, releasing free PAR fragments
Exoglycosidase activity: Preferentially binds to the two most distal ADP-ribose residues and cleaves from the ends of PAR chains, releasing mono ADP-ribose units
Enzymatic classification: EC 3.2.1.143 (glycoside hydrolase)
The catalytic process specifically targets α(1″–2′) or α(1″′–2″) glycosidic linkages in the PAR polymer . While the exoglycosidase activity predominates under normal conditions, the endoglycosidase activity becomes more important during hyper-PARP activation, such as during DNA damage responses .
The released ADP-ribose monomers are subsequently metabolized into AMP and ribose 5′ phosphate by ADP-ribose pyrophosphohydrolases like the NUDIX family enzymes . These metabolites then feed into various cellular pathways:
AMP is utilized in ATP reformation and cell signaling pathways
Ribose 5′ phosphate serves as a precursor for biomolecules including DNA, RNA, and ATP
Researchers working with recombinant PARG-1/pme-3 should consider the following methodological approaches:
E. coli expression: Both commercial sources and published protocols indicate successful expression in E. coli systems
Partial vs. full-length protein: Consider whether full-length or partial constructs are appropriate for your research question. Commercial sources offer partial constructs that may have better stability or expression yields
Typical purity: >85% as assessed by SDS-PAGE for research-grade preparations
Reconstitution: Centrifuge vials briefly before opening and reconstitute in deionized sterile water to 0.1-1.0 mg/mL
Storage buffer: Addition of glycerol (5-50% final concentration) is recommended for long-term storage
Storage temperature: -20°C/-80°C is optimal, with shelf life of approximately 12 months for lyophilized preparations and 6 months for liquid preparations
Stability considerations: Repeated freeze-thaw cycles should be avoided
PARG-1/pme-3 appears to regulate meiotic DSBs through multiple mechanisms:
Parallel pathway operation: PARG-1 operates in a pathway distinct from but parallel to the pathway involving HIM-17, HIM-5, and DSB-2
Interaction with pro-DSB factors: The HTP-3-MRE-11 axis is a key interaction point for PARG-1's pro-DSB function
Analysis of mutant phenotypes provides insights into PARG-1's role:
Synergistic effects: When parg-1 mutations are combined with mutations in him-17, him-5, or dsb-2, synergistic defects in DSB formation are observed, confirming PARG-1's operation in a parallel pathway
Protein localization: Expression and localization studies show that PARG-1 and the HIM factors (HIM-17, HIM-5, or DSB-2) are not mutually dependent, further supporting the parallel pathway model
While the precise mechanism of PARG-1's contribution to DSB formation remains under investigation, current evidence suggests it works through protein-protein interactions rather than by direct regulation of SPO-11 (the endonuclease that creates meiotic DSBs). This is supported by the observation that parg-1 mutants do not show the severe defects in bivalent formation or RAD-51 loading that would be expected if SPO-11 recruitment were compromised .
C. elegans possesses both poly(ADP-ribose) polymerases (PARPs) and PARG enzymes that work together to regulate poly(ADP-ribosyl)ation:
PME-1: 108 kDa protein with 31% identity to human PARP-1, contains zinc-finger motifs similar to other PARP-1 subfamily members
PARG-1/PME-3: The poly(ADP-ribose) glycohydrolase that reverses PARP activity
These enzymes coordinate a balanced cycle of poly(ADP-ribosyl)ation:
PME-1 and PME-2 catalyze the addition of ADP-ribose units to target proteins
PARG-1/PME-3 removes these modifications by hydrolyzing the glycosidic bonds
Studies have shown that recombinant PME-1 and PME-2 display PARP activity that accounts for the poly(ADP-ribosyl)ation observed in C. elegans extracts . The expression patterns of pme-1 and pme-2 are developmentally regulated, suggesting stage-specific functions .
Interestingly, mRNA for pme-1 is 5'-tagged with splice leader 1, whereas mRNA for pme-2 is tagged with splice leader 2, suggesting an operon-like expression pattern for pme-2 . This organization may have implications for the coordinated regulation of these enzymes.
Researchers investigating PARG-1/pme-3 can employ several methodological approaches:
Glycohydrolase activity measurement: Commercial assay kits are available that can be adapted for PARG-1 activity measurement, similar to those used for PARP3
Substrate preparation: Purified PAR polymers of defined length can be used as substrates
Product detection: Released ADP-ribose monomers can be quantified through coupled enzymatic reactions or chromatographic methods
Genetic approaches: Analysis of single and double mutants to assess genetic interactions (e.g., parg-1 with mre-11 or com-1)
Irradiation assays: Comparing DNA repair efficiency in wild-type vs. parg-1 mutants after irradiation
Immunofluorescence microscopy: Monitoring markers of DSB formation and repair (e.g., RAD-51) in germline nuclei
Co-immunoprecipitation: Using tagged versions of PARG-1 or potential interacting partners (e.g., MRE-11::GFP) to identify physical associations
Yeast two-hybrid: Screening for additional interaction partners
Proximity ligation assays: Visualizing in situ protein interactions in intact cells or tissues
Mutations in PARG-1/pme-3 have specific effects on meiotic processes:
Crossover regulation: PARG-1 influences the tightly regulated control of crossover numbers and distribution along chromosomes
DSB repair pathway choice: PARG-1 affects DNA repair pathway choice when certain other repair factors (e.g., MRE-11) are compromised
Synthetic interactions: When parg-1 mutations are combined with mutations in other DSB-promoting genes, synergistic defects in DSB formation occur
Irradiation response: In irradiation experiments, parg-1; mre-11 double mutants show repair deficiencies compared to non-irradiated controls, suggesting PARG-1 influences repair pathway choice specifically when MRE-11 function is compromised
Contrast with other pathways: Interestingly, parg-1; com-1 double mutants don't show the same deficiency, indicating pathway specificity
These findings indicate that PARG-1 has specialized roles in both promoting DSB formation and influencing their repair, with effects that become particularly evident in certain genetic backgrounds.
While detailed structural information specific to C. elegans PARG-1/pme-3 is limited in the provided search results, we can infer some characteristics:
Catalytic domain: Contains the core enzymatic region responsible for glycohydrolase activity (EC 3.2.1.143)
Conserved function: Despite evolutionary distance from mammalian PARGs, C. elegans PARG-1 retains the fundamental ability to hydrolyze PAR polymers
Functional regions: May contain both catalytic and protein interaction domains, given its dual roles in catalysis and meiotic protein interactions
Recombinant PARG-1/pme-3 proteins are available commercially in partial forms , suggesting that certain domains may be more amenable to expression and purification than others.
The research indicates that PARG-1's function in meiosis does not require its catalytic activity , pointing to the importance of non-catalytic domains in mediating protein-protein interactions with components of the meiotic machinery.
Since PARG-1/pme-3 has functions beyond its enzymatic activity, specific approaches can help dissect these roles:
Catalytically inactive mutants: Generate point mutations in the catalytic domain that abolish enzymatic activity while preserving protein structure
Domain deletion/mutation analysis: Create constructs lacking specific domains or containing mutations in interaction surfaces
Structure-function analysis: Compare phenotypes of various mutant forms to identify regions required for specific functions
Genetic separation of functions: Test whether catalytically inactive PARG-1 can rescue meiotic defects in parg-1 null mutants
Protein interaction mapping: Identify which domains of PARG-1 mediate interactions with meiotic proteins like HTP-3 and MRE-11
In vivo localization: Determine if catalytically inactive PARG-1 localizes properly to meiotic chromosomes
The finding that PARG-1 shapes the recombination landscape and regulates crossover numbers without requiring its catalytic activity provides a foundation for these investigations. Creating separation-of-function mutants would help further dissect the enzymatic versus structural roles of this protein in meiosis.